A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal maker AstraZeneca's confidential documents about its side effects before U.S. regulators decide whether to approve a version of the drug for millions of new patients.
The British drugmaker has applied to the Food and Drug Administration for approval to market Seroquel XR, the extended release version, for depression and anxiety. That would make it a possible treatment for more than 20 million Americans alone. Seroquel XR is now approved for treating schizophrenia and bipolar disorder, which affect far fewer people.
The British drugmaker has applied to the Food and Drug Administration for approval to market Seroquel XR, the extended release version, for depression and anxiety. That would make it a possible treatment for more than 20 million Americans alone. Seroquel XR is now approved for treating schizophrenia and bipolar disorder, which affect far fewer people.
No comments:
Post a Comment